Crossmark

Evidence for clinically significant prostate cancer, overdiagnosis, active surveillance, and PSA screening

Crossref DOI link: https://doi.org/10.1007/s00345-024-04905-6

Published Online: 2024-03-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takahashi, Takeshi https://orcid.org/0000-0003-4952-6305
License Information

Text and Data Mining valid from 2024-03-16

Version of Record valid from 2024-03-16
More Information

Article History

Received: 24 February 2024

Accepted: 26 February 2024

First Online: 16 March 2024

Declarations

:

: None reported.